PSMA Redirects MAPK to PI3K-AKT Signaling to Promote Prostate Cancer Progression

Molecular and Cellular Oncology - United Kingdom
doi 10.1080/23723556.2017.1321168
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

FAM83B-mediated Activation of PI3K/AKT and MAPK Signaling Cooperates to Promote Epithelial Cell Transformation and Resistance to Targeted Therapies.

Oncotarget
Oncology
2013English

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs
Cancer ResearchToxicologyOncologyPharmaceuticsPharmacology
2016English

SU6668 Modulates Prostate Cancer Progression by Downregulating MTDH/AKT Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2017English

Dampened PI3K/AKT Signaling Contributes to Cancer Resistance of the Naked Mole Rat

2020English

Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2019English

IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis

Cancer Research
Cancer ResearchOncology
2019English

PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors

Clinical Cancer Research
Cancer ResearchOncology
2019English

Erratum To: PI3K/Akt/mTOR Signaling in Medullary Thyroid Cancer: A Promising Molecular Target for Cancer Therapy

Endocrine
2016English

TIMP1 Is a Prognostic Marker for the Progression and Metastasis of Colon Cancer Through FAK-PI3K/AKT and MAPK Pathway

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy